1. Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived. Issue 1 (2nd January 2018) Authors: Farshchi Zarabi, Sara; Chan, Steven; Gupta, Vikas; Khalaf, Dina; Lutynski, Andrzej; Minden, Mark D.; Rostom, Amr; Rydlewski, Anna; Schuh, Andre C.; Sibai, Hassan; Yee, Karen W. L.; Schimmer, Aaron D. Journal: Leukemia & lymphoma Issue: Volume 59:Issue 1(2018) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗